近距離放射治療市場規模、佔有率和成長分析（按產品類型、技術、最終用戶、應用和地區分類）—產業預測，2026-2033年

預計到 2024 年，近距離放射治療市場規模將達到 8.7 億美元，到 2025 年將達到 9.4 億美元，到 2033 年將達到 17.8 億美元，在預測期（2026-2033 年）內複合年成長率為 8.3%。

由於癌症發病率上升、技術進步以及近距離放射治療作為一種治療選擇日益接受，全球近距離放射治療市場預計將迎來顯著成長。這種創新的放射線治療透過將放射性物質直接注入腫瘤部位，實現局部癌症的標靶治療。近距離放射治療使用多種放射性核種，包括銫-137、銥-192、金-198、碘-125和鈀-103，以提高療效。日益成長的癌症負擔正在推動市場擴張，因為放射線治療可以單獨使用，也可以與其他治療方法聯合使用，用於根治性、安寧療護和預防癌症。放射技術的最新進展實現了精確的劑量輸送，改善了患者的治療效果，並促進了醫生在臨床實踐中採用該療法。

近距離放射治療市場促進因素

患者對微創治療方法日益成長的偏好，大大推動了近距離放射治療市場的成長。由於其諸多優勢，例如術後併發症更少、住院時間更短、康復更快，越來越多的患者選擇此類治療方法。近距離放射治療通常在門診進行，完美契合了患者對微創治療的需求。隨著越來越多的患者尋求兼顧舒適性和便利性的有效治療方案，對近距離放射治療的需求將持續成長，進一步推動市場發展，並有助於提升腫瘤治療領域的患者照護體驗。

近距離放射治療市場限制因素

近距離放射治療的實施受到許多因素的限制，例如需要專門的設備和基礎設施來有效制定治療計劃、進行放射治療以及確保患者安全。購買和安裝這些設備需要大量的初期投入，這對醫療機構，尤其是資源匱乏地區的醫療機構而言，構成了一道難以克服的障礙。因此，儘管近距離放射治療具有改善患者照護的潛在益處，許多醫療機構仍可能對投資該療法猶豫不決。這種經濟上的限制可能會限制近距離放射治療作為一種治療選擇的發展和廣泛應用，進而影響其在醫療機構中的普及程度。

近距離放射治療市場趨勢

近距離放射治療市場正呈現出顯著的器官保留治療趨勢，這主要得益於人們對以患者生活品質為優先的標靶癌症治療需求的不斷成長。近距離放射治療對前列腺癌、乳癌和子宮頸癌等癌症尤其有效，它能夠精準地輸送輻射，同時顯著減少對周圍健康組織的損傷。這種標靶治療不僅能夠保護器官功能，也符合微創手術的整體發展趨勢。隨著醫療服務提供者和患者對這些優勢的認知不斷加深，預計近距離放射治療的應用將會進一步擴大，從而鞏固其作為腫瘤治療方法首選方案的地位。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

全球近距離放射治療市場規模（依產品類型及複合年成長率分類）（2026-2033 年）

• 種子
• 施用器/後荷機
• 電子束近距離放射治療

全球近距離放射治療市場規模（依技術及複合年成長率分類）（2026-2033 年）

• 高劑量率（HDR）
• 低劑量率（LDR）

全球近距離放射治療市場規模（依最終用戶分類）及複合年成長率（2026-2033 年）

• 醫院
• 專科診所
• 其他

全球近距離放射治療市場規模（按應用領域分類）及複合年成長率（2026-2033 年）

• 婦科癌症
• 攝護腺癌
• 乳癌
• 其他

全球近距離放射治療市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Elekta（Sweden）
• Becton, Dickinson and Company（USA）
• Eckert & Ziegler（Germany）
• Theragenics（USA）
• iCAD（USA）
• CIVCO Medical Solutions（USA）
• Isoray Medical（USA）
• Best Medical International（USA）
• AngioDynamics（USA）
• Carl Zeiss Meditec（Germany）
• Nordion（Canada）
• Oncura（UK）
• Sensus Healthcare（USA）
• IBA（Belgium）
• RaySearch Laboratories（Sweden）
• ViewRay（USA）

結論與建議

Brachytherapy Market size was valued at USD 0.87 Billion in 2024 and is poised to grow from USD 0.94 Billion in 2025 to USD 1.78 Billion by 2033, growing at a CAGR of 8.3% during the forecast period (2026-2033).

The global brachytherapy market is poised for significant growth, fueled by the rising incidence of cancer, technological advancements, and the increasing acceptance of brachytherapy as a treatment option. This innovative radiation therapy involves the insertion of radioactive materials directly into the tumor site, allowing for targeted treatment of localized cancers. Brachytherapy utilizes various radionuclides, including Caesium-137, Iridium-192, Gold-198, Iodine-125, and Palladium-103, enhancing its effectiveness. The escalating cancer burden serves as a catalyst for market expansion, as radiation therapy can be applied for curative, palliative, or prophylactic purposes, either alone or in conjunction with other treatments. The latest advancements in radiation techniques enable precise dose delivery, improving patient outcomes and driving physician adoption in clinical practice.

Top-down and bottom-up approaches were used to estimate and validate the size of the Brachytherapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Brachytherapy Market Segments Analysis

Global Brachytherapy Market is segmented by Product Type, Technique, End User, Application and region. Based on Product Type, the market is segmented into Seeds, Applicators and Afterloaders and Electronic Brachytherapy. Based on Technique, the market is segmented into High Dose Rate (HDR) and Low Dose Rate (LDR). Based on End User, the market is segmented into Hospitals, Specialty Clinics and Others. Based on Application, the market is segmented into Gynecological Cancer, Prostate Cancer,breast cancerand Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Brachytherapy Market

The growing preference among patients for minimally invasive treatment options significantly influences the expansion of the brachytherapy market. Due to their association with fewer post-operative complications, shorter hospital stays, and quicker recovery periods, patients are increasingly opting for these procedures. Brachytherapy, which is often performed on an outpatient basis, aligns perfectly with this desire for less invasive options. As more individuals seek effective treatments that prioritize comfort and convenience, the demand for brachytherapy continues to rise, further driving market growth and enhancing patient care experiences in oncology.

Restraints in the Brachytherapy Market

The adoption of brachytherapy is hindered by the need for specialized equipment and infrastructure essential for effective treatment planning, radiation delivery, and ensuring patient safety. The considerable initial expenses associated with purchasing and installing this equipment present a significant barrier for healthcare facilities, particularly those in resource-limited areas. As a result, many institutions may hesitate to invest in brachytherapy solutions, which could otherwise enhance patient care. This financial constraint potentially limits the growth and accessibility of brachytherapy as a treatment option, thus impacting its overall adoption in various healthcare settings.

Market Trends of the Brachytherapy Market

The Brachytherapy market is witnessing a notable trend towards organ-preserving treatments, driven by the rising demand for targeted cancer therapies that prioritize patient quality of life. Particularly effective for cancers like prostate, breast, and cervical cancer, brachytherapy enables precise radiation delivery while significantly reducing harm to surrounding healthy tissues. This targeted approach not only maintains organ function but also aligns with the broader shift towards minimally invasive procedures. As healthcare providers and patients increasingly embrace these advantages, the adoption of brachytherapy is expected to grow, further solidifying its role as a preferred treatment modality in oncology.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Brachytherapy Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Seeds
• Applicators and Afterloaders
• Electronic Brachytherapy

Global Brachytherapy Market Size by Technique & CAGR (2026-2033)

• Market Overview
• High Dose Rate (HDR)
• Low Dose Rate (LDR)

Global Brachytherapy Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Specialty Clinics
• Others

Global Brachytherapy Market Size by Application & CAGR (2026-2033)

• Market Overview
• Gynecological Cancer
• Prostate Cancer
• Breast Cancer
• Others

Global Brachytherapy Market Size & CAGR (2026-2033)

• North America (Product Type, Technique, End User, Application)
  • US
  • Canada
• Europe (Product Type, Technique, End User, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Technique, End User, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Technique, End User, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Technique, End User, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Elekta (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eckert & Ziegler (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Theragenics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• iCAD (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CIVCO Medical Solutions (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Isoray Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Best Medical International (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Carl Zeiss Meditec (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nordion (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oncura (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sensus Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IBA (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RaySearch Laboratories (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ViewRay (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations